Home > Food & Beverages > Nutraceuticals > Melatonin Products Market

Melatonin Products Market Trends

Report ID: GMI7015
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Melatonin Products Market Trends

Consumers are increasingly seeking natural and herbal solutions for sleep disorders and insomnia. Melatonin, as a naturally occurring hormone, fits into this trend, and products positioned as natural sleep aids have gained popularity. In addition, precision dosing has become a trend, with manufacturers offering melatonin products in varying dosages to cater to individual preferences and needs. Some products are marketed as "low dose" melatonin for users who want a milder sleep aid.

Authors: Kunal Ahuja, Himanshu Kabra

Frequently Asked Questions (FAQ) :

The market size of melatonin products was worth USD 1.56 billion in 2022 and will reach USD 5.95 billion by 2032, due to the growing awareness of sleep disorders, such as insomnia and sleep apnea, among the global population.

Melatonin products market size from the synthetic melanin type segment reached USD 2.5 billion in 2022 and is expected register commendable CAGR from 2023 to 2032, on account of the increasing prevalence of sleep disorders and disturbances in modern society.

North America melatonin products market size crossed USD 0.55 billion in 2022 and is expected to register appreciable CAGR from 2023 to 2032, owing to the rising modern lifestyles, increasing screen time, and high-stress levels resulting in the prevalence of sleep disorders in the region.

Aspen Holdings, Nature's Bounty, Pfizer Inc., Natrol, LLC (an Aurobindo company), Biotics Research Corporation, Solgar, Now Foods, GNC, and Sundown Naturals are some of the major melatonin products companies worldwide.